Evonik Industries AG annual cash and equivalents
2021
2022
2023
2024
2025
Evonik Industries AG Cash & Equivalents Growth & History (EVK)
Evonik Industries AG's cash and equivalents was €495.0M for fiscal 2025.
View full Evonik Industries AG company overviewEvonik Industries AG annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €495.0M | €34.0M | +7.38% |
| 2024 | 2024-12-31 | €461.0M | −€288.0M | −38.45% |
| 2023 | 2023-12-31 | €749.0M | €104.0M | +16.12% |
| 2022 | 2022-12-31 | €645.0M | €189.0M | +41.45% |
| 2021 | 2021-12-31 | €456.0M | — | — |
Evonik Industries AG quarterly cash and equivalents
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €390.0M | €11.0M | +2.90% |
| Q1 2026 | 2026-03-31 | €589.0M | −€144.0M | −19.65% |
| Q4 2025 | 2025-12-31 | €495.0M | — | — |
| Q2 2025 | 2025-06-30 | €379.0M | — | — |
| Q1 2025 | 2025-03-31 | €733.0M | — | — |
Evonik Industries AG cash and equivalents trends
Between the periods ended 2021-12-31 and 2025-12-31, Evonik Industries AG's cash and equivalents increased from €456.0M to €495.0M, a change of €39.0M. The latest reported quarter, Q2 2026, shows €390.0M.
About the metric
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Calculation and source
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evonik Industries AG source filings ↗Community posts
Evonik declines takeover negotiations after BASF improves its approach
Evonik ($EVK)’s executive board declined to enter takeover negotiations with BASF ($BAS) after reviewing the larger chemicals group’s renewed approach. Reuters reported that the improved proposal values Evonik at €24 a share, or approximate ...
Evonik reportedly rejects BASF’s €10.3 billion takeover approach
Evonik ($EVK) has rejected a BASF ($BAS) takeover proposal worth approximately €10.3 billion, or €22.15 per share, as inadequate, according to Reuters sources. BASF said its approach remained disciplined and that assessing potential synergi ...
